299 related articles for article (PubMed ID: 28295224)
1. Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
Tluway F; Makani J
Br J Haematol; 2017 Jun; 177(6):919-929. PubMed ID: 28295224
[TBL] [Abstract][Full Text] [Related]
2. Curative options for sickle cell disease in Africa: Approach in Tanzania.
Makani J;
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):66-70. PubMed ID: 32201150
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
[TBL] [Abstract][Full Text] [Related]
4. Is sickle cell disease sufficiently prioritized in policy and socio-economic research on diseases in Tanzania? Lessons for the past 50 years.
Mubyazi GM; Njunwa KJ
Tanzan J Health Res; 2011 Dec; 13(5 Suppl 1):340-51. PubMed ID: 26591989
[TBL] [Abstract][Full Text] [Related]
5. Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality.
Makani J; Soka D; Rwezaula S; Krag M; Mghamba J; Ramaiya K; Cox SE; Grosse SD
Trop Med Int Health; 2015 Feb; 20(2):184-7. PubMed ID: 25365928
[TBL] [Abstract][Full Text] [Related]
6. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
[TBL] [Abstract][Full Text] [Related]
7. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell disease in the Zanzibar Archipelago, the Republic of Tanzania.
Richert W; Atumani MO; Kołodziej D; Korzeniewski K
Int Marit Health; 2024; 75(1):43-48. PubMed ID: 38647058
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India.
Nimgaonkar V; Krishnamurti L; Prabhakar H; Menon N
Pediatr Blood Cancer; 2014 Apr; 61(4):702-5. PubMed ID: 24347362
[TBL] [Abstract][Full Text] [Related]
10. Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
Hegemann L; Narasimhan V; Marfo K; Kuma-Aboagye P; Ofori-Acquah S; Odame I
Ann Glob Health; 2023; 89(1):76. PubMed ID: 38025926
[TBL] [Abstract][Full Text] [Related]
11. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
Odame I
Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
[TBL] [Abstract][Full Text] [Related]
12. A global perspective on sickle cell disease.
Aygun B; Odame I
Pediatr Blood Cancer; 2012 Aug; 59(2):386-90. PubMed ID: 22535620
[TBL] [Abstract][Full Text] [Related]
13. Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania.
Christopher H; Burns A; Josephat E; Makani J; Schuh A; Nkya S
BMC Genomics; 2021 Dec; 22(1):902. PubMed ID: 34915846
[TBL] [Abstract][Full Text] [Related]
14. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
Smart LR; Ambrose EE; Raphael KC; Hokororo A; Kamugisha E; Tyburski EA; Lam WA; Ware RE; McGann PT
Ann Hematol; 2018 Feb; 97(2):239-246. PubMed ID: 29147848
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of maternal health education and maternal screening on knowledge and the uptake of infant screening for sickle cell disease in Dar-Es-Salaam, Tanzania; a quasi experimental study.
Tutuba HJ; Jonathan A; Lloyd W; Masamu U; Marco E; Makani J; Ruggajo P; Kidenya BR; Minja IK; Balandya E
BMC Public Health; 2023 Jan; 23(1):70. PubMed ID: 36627609
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell disease: current activities, public health implications, and future directions.
Creary M; Williamson D; Kulkarni R
J Womens Health (Larchmt); 2007 Jun; 16(5):575-82. PubMed ID: 17627395
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
Diallo DA; Guindo A
Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
[TBL] [Abstract][Full Text] [Related]
19. Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.
Odame I; Kulkarni R; Ohene-Frempong K
Am J Prev Med; 2011 Dec; 41(6 Suppl 4):S417-21. PubMed ID: 22099367
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell disease: Reducing the global disease burden.
Mburu J; Odame I
Int J Lab Hematol; 2019 May; 41 Suppl 1():82-88. PubMed ID: 31069977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
